These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25808613)

  • 1. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents.
    Sohn M; Talbert J; Blumenschein K; Moga DC
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):583-91. PubMed ID: 25808613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson TM; Xie J; Erder MH; Dammerman RS; Robertson B; Wu EQ
    Am J Manag Care; 2014 Sep; 20(9):711-21. PubMed ID: 25365746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case-control study.
    Lee H; Song DH; Kwon JW; Han E; Chang MJ; Kang HY
    Eur Child Adolesc Psychiatry; 2018 Oct; 27(10):1321-1334. PubMed ID: 29460164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):642-651. PubMed ID: 28735693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.
    Lachaine J; De G; Sikirica V; Van Stralen J; Hodgkins P; Yang H; Heroux J; Ben Amor L
    Can J Psychiatry; 2014 Nov; 59(11):597-608. PubMed ID: 25565476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Risk of Diabetes Among 6-24-Year-Olds Using Second Generation Antipsychotics.
    Xing S; Lee TA
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):782-791. PubMed ID: 28799787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.
    Rubin DM; Kreider AR; Matone M; Huang YS; Feudtner C; Ross ME; Localio AR
    JAMA Pediatr; 2015 Apr; 169(4):e150285. PubMed ID: 25844991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.
    Bali V; Kamble PS; Aparasu RR
    J Atten Disord; 2019 Jan; 23(2):163-172. PubMed ID: 26494504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly.
    Mehta S; Pulungan Z; Jones BT; Teigland C
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1271-80. PubMed ID: 26445931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National trends in off-label use of atypical antipsychotics in children and adolescents in the United States.
    Sohn M; Moga DC; Blumenschein K; Talbert J
    Medicine (Baltimore); 2016 Jun; 95(23):e3784. PubMed ID: 27281081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
    Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
    Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.
    Bobo WV; Cooper WO; Stein CM; Olfson M; Graham D; Daugherty J; Fuchs DC; Ray WA
    JAMA Psychiatry; 2013 Oct; 70(10):1067-75. PubMed ID: 23965896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Events Following Treatment Initiation with Atypical Antipsychotic Medications in Publicly Insured U.S. Youth.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    J Child Adolesc Psychopharmacol; 2018 Sep; 28(7):445-453. PubMed ID: 29975555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA; Joyce AT; Rucker M
    MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.